JimBowie1958
Old Fogey
- Sep 25, 2011
- 63,590
- 16,753
- 2,220
That seems to be what is going to happen.
Happy New Years to all you fudge packers out there; you can return to bare-backin' in no time!
Scientists are genetically engineering immune systems to attack and destroy HIV
Perhaps the most notable finding researchers documented was that the engineered cells killed HIV-infected cells in petri dishes and in two macaque monkeys for a full two years. “These results set the stage for future attempts to eradicate viral infection and provide more effective immune surveillance for HIV,” the study says.
The researchers did note that their technique did not eradicate infected cells in which the HIV virus was dormant. For that reason, they say, future studies should focus on a combination approach to treatment. That would mean engineering cells to attack HIV infections while also making the blood system resistant to infection.
According to STAT, human trials of this treatment technique could begin within the next two years. The researchers are currently in communication with Calimmune, a Tucson, Arizona-based HIV gene medicines laboratory, to advance the project.
Happy New Years to all you fudge packers out there; you can return to bare-backin' in no time!
Scientists are genetically engineering immune systems to attack and destroy HIV
Perhaps the most notable finding researchers documented was that the engineered cells killed HIV-infected cells in petri dishes and in two macaque monkeys for a full two years. “These results set the stage for future attempts to eradicate viral infection and provide more effective immune surveillance for HIV,” the study says.
The researchers did note that their technique did not eradicate infected cells in which the HIV virus was dormant. For that reason, they say, future studies should focus on a combination approach to treatment. That would mean engineering cells to attack HIV infections while also making the blood system resistant to infection.
According to STAT, human trials of this treatment technique could begin within the next two years. The researchers are currently in communication with Calimmune, a Tucson, Arizona-based HIV gene medicines laboratory, to advance the project.